Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial

Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial

Bibliographic Details
Main Authors: Faries, Douglas, Ascher-Svanum, Haya, Phillips, Glenn, Nyhuis, Allen W, Sugihara, Tomoko, Stauffer, Virginia, Kinon, Bruce J
Format: Online
Language:English
Published: BioMed Central 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505169/
id pubmed-3505169
recordtype oai_dc
spelling pubmed-35051692012-11-24 Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial Faries, Douglas Ascher-Svanum, Haya Phillips, Glenn Nyhuis, Allen W Sugihara, Tomoko Stauffer, Virginia Kinon, Bruce J Research Article BioMed Central 2012-09-13 /pmc/articles/PMC3505169/ /pubmed/22974273 http://dx.doi.org/10.1186/1471-2288-12-142 Text en Copyright ©2012 Faries et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Faries, Douglas
Ascher-Svanum, Haya
Phillips, Glenn
Nyhuis, Allen W
Sugihara, Tomoko
Stauffer, Virginia
Kinon, Bruce J
spellingShingle Faries, Douglas
Ascher-Svanum, Haya
Phillips, Glenn
Nyhuis, Allen W
Sugihara, Tomoko
Stauffer, Virginia
Kinon, Bruce J
Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial
author_facet Faries, Douglas
Ascher-Svanum, Haya
Phillips, Glenn
Nyhuis, Allen W
Sugihara, Tomoko
Stauffer, Virginia
Kinon, Bruce J
author_sort Faries, Douglas
title Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial
title_short Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial
title_full Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial
title_fullStr Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial
title_full_unstemmed Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial
title_sort construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial
description
publisher BioMed Central
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505169/
_version_ 1611934923477745664

Similar Items